突发性耳聋伴眩晕的临床分析

目的 探讨突发性耳聋（简称突聋）伴良性阵发性位置性眩晕（BPPV）或突聋伴眩晕综合征（非BPPV）与突聋不伴眩晕的临床特征及疗效。方法 选取2018年1月—2019年12月收治的400例突聋患者，根据是否伴有眩晕症状，分为突聋伴眩晕组（163例）和突聋不伴眩晕组（237例）两组。163例突聋伴眩晕组患者进一步分为突聋伴BPPV组（97例）和突聋伴非BPPV组（66例）。所有入院患者行纯音测听、声导抗、耳声发射检查，根据不同听力曲线采用分型治疗，记录不同分组的听力疗效。结果 突聋伴BPPV组与突聋伴非BPPV组比较，两组听力有效改善率无统计学意义（P>0.05）；突聋不伴眩晕组听力有效改善率明显高于突聋伴BPPV组及突聋伴非BPPV组（P<0.05）。结论 对于突聋伴BPPV或突聋伴非BPPV，其听力疗效基本一致，突聋伴BPPV或突聋伴非BPPV患者，眩晕是影响其听力疗效及预后的关键因素之一。

Clinical analysis of sudden hearing loss with vertigo

Objective To investigate the clinical features and efficacy of sudden hearing loss with vertigo including benign paroxysmal positional vertigo (BPPV) or non-BPPV and sudden hearing loss without vertigo. Methods From Jan 2018 to Dec 2019, 400 patients with sudden hearing loss were enrolled. They were divided into two groups according to whether accompanied by vertigo or not, 163 cases belonged to the group with vertigo and 237 without vertigo. The group with vertigo was further subdivided into BPPV group and vertigo syndrome (non-BPPV) group. All patients had pure audiometry, acoustic conductance, otoacoustic emission examination. Classification therapy was adopted according to different hearing curves and the hearing effects of different groups were recorded and compared. Results The difference of effective rate between the BPPV group and non-BPPV group was statistically insignificant (P>0.05). The effective rate of the group without vertigo was significantly higher than those of the BPPV group and the non-BPPV group (both P<0.05). Conclusion The hearing effect of sudden hearing loss with BPPV is similar to that of sudden hearing loss with vertigo syndrome (non-BPPV). Vertigo is one of the key factors affecting the hearing efficacy and prognosis.